{
    "startDate": "2019-01-01",
    "endDate": "2019-12-31",
    "year": "2019",
    "quarter": "FY",
    "symbol": "BBIO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 363773000
            },
            {
                "label": "Short-term marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 182220000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 22629000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 568622000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 5625000
            },
            {
                "label": "Long-term marketable securities",
                "concept": "MarketableSecuritiesNoncurrent",
                "unit": "usd",
                "value": 31144000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 26288000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 631679000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 8852000
            },
            {
                "label": "Accrued compensation and benefits",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 13317000
            },
            {
                "label": "Accrued research and development liabilities current.",
                "concept": "bbio:AccruedResearchAndDevelopmentLiabilitiesCurrent",
                "unit": "usd",
                "value": 20896000
            },
            {
                "label": "Accrued professional services",
                "concept": "AccruedProfessionalFeesCurrent",
                "unit": "usd",
                "value": 2222000
            },
            {
                "label": "LEO call option liability current.",
                "concept": "bbio:LEOCallOptionLiabilityCurrent",
                "unit": "usd",
                "value": 4078000
            },
            {
                "label": "Build-to-suit lease obligation current.",
                "concept": "bbio:BuildToSuitLeaseObligationCurrent",
                "unit": "usd",
                "value": 8000000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 3020000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 60385000
            },
            {
                "label": "Term loans, noncurrent",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 91791000
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 3527000
            },
            {
                "label": "Current liabilities:",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 155703000
            },
            {
                "label": "Commitments and contingencies (Note 9)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Redeemable convertible noncontrolling interests",
                "concept": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
                "unit": "usd",
                "value": 2243000
            },
            {
                "label": "Undesignated preferred stock, $0.001 par value; 25,000,000 and no shares authorized as of December 31, 2019 and 2018; no shares issued and outstanding as of December 31, 2019 and 2018",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.001 par value; 500,000,000 and 97,412,870 shares authorized as of December 31, 2019 and 2018, respectively; 123,658,287 and 92,057,704 shares issued and outstanding as of December 31, 2019 and 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 124000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 848107000
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 254000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -440031000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 408454000
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 65279000
            },
            {
                "label": "Total stockholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 473733000
            },
            {
                "label": "Total liabilities, redeemable convertible noncontrolling interests and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 631679000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -288585000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 21374000
            },
            {
                "label": "Share in net loss of equity method investments",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -20869000
            },
            {
                "label": "Fair value of equity method investment.",
                "concept": "bbio:FairValueOfEquityMethodInvestment",
                "unit": "usd",
                "value": -3819000
            },
            {
                "label": "Accretion of term loans and convertible promissory notes",
                "concept": "AccretionExpense",
                "unit": "usd",
                "value": 1509000
            },
            {
                "label": "Acquired in-process research and development assets",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 3560000
            },
            {
                "label": "Call option expense.",
                "concept": "bbio:CallOptionExpense",
                "unit": "usd",
                "value": 1069000
            },
            {
                "label": "Other noncash adjustments",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -1351000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 13492000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 16929000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -4657000
            },
            {
                "label": "Accrued compensation and benefits",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": 9270000
            },
            {
                "label": "Increase (decrease) in accrued research and development liabilities.",
                "concept": "bbio:IncreaseDecreaseInAccruedResearchAndDevelopmentLiabilities",
                "unit": "usd",
                "value": 11981000
            },
            {
                "label": "Increase decrease in accrued professional services.",
                "concept": "bbio:IncreaseDecreaseInAccruedProfessionalServices",
                "unit": "usd",
                "value": 1450000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
                "unit": "usd",
                "value": 1527000
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": -65000
            },
            {
                "label": "Operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -253587000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 212899000
            },
            {
                "label": "Cash paid for in-process research and development assets acquired",
                "concept": "PaymentsToAcquireInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": 2500000
            },
            {
                "label": "Cash and cash equivalents acquired in ML Bio asset acquisition",
                "concept": "CashAcquiredFromAcquisition",
                "unit": "usd",
                "value": 784000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 2638000
            },
            {
                "label": "Investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -217253000
            },
            {
                "label": "Proceeds from issuance of common stock in connection with the initial public offering of the Corporation in 2019 and Eidos in 2018, net of underwriting discounts and commissions",
                "concept": "ProceedsFromIssuanceInitialPublicOffering",
                "unit": "usd",
                "value": 366237000
            },
            {
                "label": "Stock Issued No Premium",
                "concept": "bbio:StockIssuedNoPremium",
                "unit": "usd",
                "value": 23309000
            },
            {
                "label": "Proceeds from repayment of nonrecourse notes",
                "concept": "ProceedsFromRepaymentsOfSecuredDebt",
                "unit": "usd",
                "value": 179000
            },
            {
                "label": "Proceeds from term loans, net of issuance costs",
                "concept": "ProceedsFromDebtNetOfIssuanceCosts",
                "unit": "usd",
                "value": 36939000
            },
            {
                "label": "Proceeds from at-the-market issuance of noncontrolling interest by Eidos",
                "concept": "ProceedsFromMinorityShareholders",
                "unit": "usd",
                "value": 23927000
            },
            {
                "label": "Proceeds from third party investors in redeemable convertible noncontrolling interests.",
                "concept": "bbio:ProceedsFromThirdPartyInvestorsInRedeemableConvertibleNoncontrollingInterests",
                "unit": "usd",
                "value": 1500000
            },
            {
                "label": "MyoKardia distributions",
                "concept": "PaymentsOfDividends",
                "unit": "usd",
                "value": 997000
            },
            {
                "label": "Repurchase of noncontrolling interest",
                "concept": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
                "unit": "usd",
                "value": 55011000
            },
            {
                "label": "Proceeds from BridgeBio common stock issuances under ESPP",
                "concept": "ProceedsFromStockPlans",
                "unit": "usd",
                "value": 921000
            },
            {
                "label": "Proceeds from stock option exercises",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 1788000
            },
            {
                "label": "Financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 398792000
            },
            {
                "label": "Net (decrease) increase in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -72048000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 6092000
            },
            {
                "label": "Tenant improvement paid by landlord",
                "concept": "PaymentsForTenantImprovements",
                "unit": "usd",
                "value": 2097000
            },
            {
                "label": "Noncash or part noncash investing transfer (from) to noncontrolling interest.",
                "concept": "bbio:NoncashOrPartNoncashInvestingTransferFromToNoncontrollingInterest",
                "unit": "usd",
                "value": -28635000
            },
            {
                "label": "Build-to-suit funding liability accrual (Note 14)",
                "concept": "ConstructionInProgressExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 8000000
            },
            {
                "label": "Fair value of success fee derivative at issuance of term loan.",
                "concept": "bbio:FairValueOfSuccessFeeDerivativeAtIssuanceOfTermLoan",
                "unit": "usd",
                "value": 1148000
            }
        ],
        "ic": [
            {
                "label": "License revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 40560000
            },
            {
                "label": "Cost of license revenue.",
                "concept": "bbio:CostOfLicenseRevenue",
                "unit": "usd",
                "value": 2500000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 209947000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 94353000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 306800000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -266240000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 8915000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 8765000
            },
            {
                "label": "Business combination loss on asset acquisitions.",
                "concept": "bbio:BusinessCombinationLossOnAssetAcquisitions",
                "unit": "usd",
                "value": 416000
            },
            {
                "label": "Share in net loss of equity method investments",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -20869000
            },
            {
                "label": "Other expense",
                "concept": "OtherNonoperatingExpense",
                "unit": "usd",
                "value": 1210000
            },
            {
                "label": "Other income (expense), net:",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -22345000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -288585000
            },
            {
                "label": "Net loss attributable to redeemable convertible noncontrolling interests and noncontrolling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -27998000
            },
            {
                "label": "Net loss attributable to common stockholders of BridgeBio",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -260587000
            },
            {
                "label": "Net loss per share, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -2.48
            },
            {
                "label": "Weighted-average shares used in computing net loss per share, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 105099089
            },
            {
                "label": "Unrealized gain on available-for-sale securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 254000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -288331000
            },
            {
                "label": "Comprehensive loss attributable to redeemable convertible noncontrolling interests and noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -27998000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -260333000
            }
        ]
    }
}